CancerFree KIDS Awards 10 Grants to Cincinnati Children’s
Post Date: November 30, 2023 | Publish Date:
CancerFree KIDS has continued its generous giving in the form of grants to 10 research projects at Cincinnati Children’s. The total amount awarded to research programs this round was $600,000.
With this year’s investments, the total grant funding to date from CancerFree KIDS to Cincinnati Children’s is over $6M.
“CancerFree KIDS is a central part of our team and a central part of innovation,” says John Perentesis, MD, director of the Division of Oncology, and co-executive director of the Cancer and Blood Diseases Institute. “Their funding allows us to look at transformational big leaps and how we think about cancer to treat and cure kids for whom regular therapies don’t work.”
The Loveland-based nonprofit said the grants, which range from $50,000 to $100,000 per project, would help fund studies of new AML therapies, CAR-T cell therapy, CAR-T cell therapy on DIPG, and more.
“We are thrilled to be able to fund promising pediatric cancer research at Cincinnati Children’s Hospital with this grant,” says Jill Brinck, Executive Director of CancerFree KIDS. “We are also grateful to our many supporters, who make life-changing investments like this happen.”
The Cincinnati Children’s projects are:
New Idea Awards $50,000:
- altafiber Research Grant: Arman Bayat; Targeting DIPG/DMG with innovative proton therapy
- DBL Law Research Grant: Daniel Starczynowski, PhD; Developing novel UBE2N inhibitors for cancer using DNA-encoded library screen
- Gusweiler Friends & Family Research Grant: Xin Duan; Developing a Novel Strategy to Treat Juvenile Myelomonocytic Leukemia
- Interlink Cloud Advisors Research Grant: Bailee Kain, PhD; Utilizing a human stem cell derived bone marrow organoid model to study AML
- Jersey Mike’s Research Grant: Liang Hu, RDMS; Agonist therapy for malignant peripheral nerve sheath tumors
- Maddie’s Hope Research Grant: Anusha Anukanth, MD; Exploring the role of feeder cells in NK cell priming
- Schroth Family Research Grant: Ramesh Nayak, PhD; SATB2, a novel target to eradicate leukemia initiating cells (LIC) in B-cell acute lymphoblastic leukemia (B-ALL).
- Wirtz Family Research Grant in Memory of Jacob: Mohammad Azam, PhD; Targeting immune-resistance to CAR-T cell therapy in B-ALL
Accelerator Award $100,000:
Wolf Pack Research Grant in memory of Grant Wolf: Zaili Luo, PhD; Novel chimeric antigen receptor T-cell immunotherapy for diffuse midline gliomas
The ENGRAFT Learning Network $100,000:
The BFF Fund Research Grant: Stella Davies, MBBS, PhD, MRCP; ENGRAFT – a Transplant and Cellular Therapy Learning Network
